From a therapeutic point of view, it is interesting to note that the combination of MEK5 or ERK5 inhibitors with the BRAFV600E inhibitor vemurafenib is more effective than single treatments in decreasing colony formation and proliferation of BRAFV600E melanoma cells and growth of melanoma xenografts [63]. The gene discussed is MAP2K5; the disease is melanoma.